论文部分内容阅读
近年来发展的长效支气管扩张剂班布特罗是 β2 受体激动剂特布他林的前体药 ,口服后在体内经血浆丁基胆碱酯酶水解释放出特布他林发挥支气管扩张作用 ,其半衰期长 ,持续时间可达 2 4h ,副作用少 ,适用于夜间哮喘及老年哮喘的治疗 ,是一种具有很大应用价值的新药
In recent years, the development of long-acting bronchodilator Bambuterol β2 receptor agonist terbutaline in the prodrug of oral administration of butyrylcholinesterase in the body after the release of terbutaline to play bronchodilation Role, its long half-life, duration up to 24h, fewer side effects, suitable for the treatment of asthma and asthma at night, is a great value of the new drug